Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. - Wikidata - awgldk - TriplyDB

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.

http://www.wikidata.org/entity/Q53113911

about

Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries.Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group.Predictors of antiemetic alteration in pediatric acute myeloid leukemia.Aprepitant reduces chemotherapy-induced vomiting in children and young adults with brain tumors.Determinants of implementation of maternal health guidelines in Kosovo: mixed methods study.Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation.Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.Comparative effectiveness research in antineoplastic-induced nausea and vomiting control in children.Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients.The safety of olanzapine in young children: a systematic review and meta-analysis.Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study.Current variations in childhood cancer supportive care in the Netherlands.Palonosetron compared with ondansetron in pediatric cancer patients: multicycle analysis of a randomized Phase III study.Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update.Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer.The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis.Nausea and vomiting in children and adolescents receiving intrathecal methotrexate: A prospective, observational study.Aprepitant in pediatric patients using moderate and highly emetogenic protocols: a systematic review and meta-analyses of randomized controlled trials.Patients' and parents' views regarding supportive care in childhood cancer.2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children.Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.Aprepitant and fosaprepitant drug interactions: a systematic review.Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.Development of clinical practice guidelines for supportive care in childhood cancer--prioritization of topics using a Delphi approach.Improving Adherence to Evidence-Based Guidelines for Chemotherapy-Induced Nausea and Vomiting.IV Administration of Erwinia-Derived Asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia: Single-Centre Case Series.Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial.Evaluation of aprepitant for acute chemotherapy-induced nausea and vomiting in children and adolescents with acute lymphoblastic leukemia receiving high-dose methotrexate.Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate.Prevention of chemotherapy-induced vomiting in children receiving multiple-day cisplatin chemotherapy: A hospital-based, retrospective cohort study.

P2860

Q33423131-44F0C3D7-8A73-4E02-8F78-8729529743B2 Q33762835-7243718F-3F9E-4C5D-B0DE-C7E262771411 Q33925192-FAA911FA-3533-43D8-B62C-5D0181F3B21F Q34076359-A7A58E6D-D996-4EFA-9BFE-C92BCF2833C4 Q35627742-E32293B7-1952-4050-B053-E3EBDC511C4D Q37355816-8D5ADD0F-CB2A-44C5-8ED4-023792E7905F Q37476200-FD3D2F3F-03AD-418D-B0A0-C88CE7541FED Q37660511-C00B4183-5A18-4F97-89BF-A572B19113D5 Q38068800-F27352F4-8B8F-4D6E-B627-5CC4AC45C1FB Q38197218-C534CA51-84DD-4CE9-81C2-5694CC5A7007 Q38206168-E20E9C57-EC3B-4809-A064-435D5232A6DB Q38242011-01112FEA-5AC2-4575-90CD-286485C2DEF3 Q38635282-4F9462F3-FDAB-48DC-8217-4E6109E33BBC Q38640416-9936B50D-20DC-4219-B220-906EC4BA9AF8 Q38676345-EA4FF5FB-D31A-436D-B6B1-FE1167B91C7E Q38689818-72203D0D-0384-4040-9002-35EDB69FD944 Q38767176-93B236D6-DD3B-4B68-96CB-C42F921D977B Q38785094-75E9AF9B-DFF4-4596-A49F-0C731430F2FB Q38788280-BA379012-297B-4421-979C-D0DA2779CAF9 Q38792913-E3B32F81-C6DE-40C0-87B7-53A273AA4AC5 Q38812560-0A1D206D-690D-4824-87DE-9C0A8AC68EFB Q38938275-FE62BFA1-683E-4109-98A9-11EAA8CDB725 Q38969688-91094DFD-A1D6-460C-A96C-7A92D0BBDE4B Q39266110-CE8F7AFD-9383-4F1E-B965-76F83B1FC59C Q39282847-C3DE299C-C542-44F1-8CEE-D5CED2703CEB Q41103220-CE9BD485-7F77-4690-AC51-33E3886ADBCD Q41595378-36032CA3-A1D1-42B7-82C0-C59917EF69D1 Q41598410-94F8D1F7-84AC-4A92-A2BD-1AC45D913CE6 Q42001967-B718656D-53E6-4F93-BB66-14C9A52825C1 Q47549281-C16012AC-58B7-4192-8EEE-C986C5B3BF9F Q47562308-2DCAC721-D459-4DA0-AFE0-0D4242233640 Q48186671-C973D5A8-F08E-4336-9D35-07A6A3388491 Q48301987-EE457F5F-78BC-4834-9B25-C94FEC688B59 Q50565014-C0E2C861-83E0-42BB-85A6-6A624C9A22B9 Q54127832-A806C3E5-4A29-45A9-989E-4A6292AAFC62

P2860

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.

http://www.wikidata.org/entity/Q53113911

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Guideline for the prevention o ...... in pediatric cancer patients.

@en

Guideline for the prevention o ...... in pediatric cancer patients.

@nl

type

label

Guideline for the prevention o ...... in pediatric cancer patients.

@en

Guideline for the prevention o ...... in pediatric cancer patients.

@nl

prefLabel

Guideline for the prevention o ...... in pediatric cancer patients.

@en

Guideline for the prevention o ...... in pediatric cancer patients.

@nl

P1433

Q53113911-07FBF07C-1327-4E8F-91D9-2AAA69537030

P1476

Q53113911-A9A4ED88-A0AC-43D2-B565-F24D5AC34EE1

P2093

Q53113911-0DB0B481-3EC7-4948-8FC6-8710ED425FF4

Q53113911-159DFE0B-EB03-44EF-A8CA-AF463AB10359

Q53113911-16131681-7641-400A-8289-51F15E15CEFE

Q53113911-3B253D4A-14E4-4B76-A2F2-BDC837E97131

Q53113911-9BC06C3B-C48D-44C9-B20D-2387EAD6B572

Q53113911-C7DDA184-F514-4A96-B473-04A8E540228E

Q53113911-CEAFCCC9-F63D-4339-8E73-DAC617CFC3CC

Q53113911-F197EEDA-22EB-4527-A639-D98D28A759AE

P2860

Q53113911-0015915A-21E8-4F88-AA7B-D986880AAD2E

Q53113911-0ECF8666-6E70-4AA4-991C-84D2E1373E46

Q53113911-19E0A25B-5CA2-4F20-B2FF-5E95A9A9E195

Q53113911-1FBF5DC8-BBCE-44F4-AF02-96FA89725343

Q53113911-211E71B5-80CA-4F6B-AF75-D9540166BDA2

Q53113911-25C6F836-ED98-4CD3-B44A-60B13B156DC8

Q53113911-33F3B20E-FCF4-43E6-9297-73657A03DF01

Q53113911-36D9BC38-60F4-4AB1-B496-A2C55981605B

Q53113911-45C7D9E8-FDCC-4641-90C1-C3084AC58E77

Q53113911-5D8E7CF7-9126-4C08-87BE-4DE960F49EB1

P304

Q53113911-F5988C27-08ED-4482-88A9-CA783BEE9259

P31

Q53113911-7F551090-807D-45B6-B664-2201945E69CC

P356

Q53113911-7BFC1D2D-9960-4669-AC83-140199EEF143

P433

Q53113911-8295A1F2-44E0-4962-9406-105784DC8D35

P478

Q53113911-28115381-52EC-448B-B914-2B41F43665F7

P50

Q53113911-CA3FF945-C7A6-4E33-9E39-F42BFC1C1B20

P577

Q53113911-B6F2C733-1850-49B7-A924-52EFB5A5003A

P5875

Q53113911-95FC64CB-2AB5-4292-AA56-FF28ACFE3369

P698

Q53113911-5EB6E34F-ED0F-47E2-9E72-0BA78607DB47

P921

Q53113911-838F453A-9738-4ADC-AF60-C6AB700C2927

P356

P1433

Pediatric Blood & Cancer

P1476

Guideline for the prevention o ...... n in pediatric cancer patients

@en

P2093

Carol Portwine

http://www.w3.org/2001/XMLSchema#string

Erin O'Shaughnessy

http://www.w3.org/2001/XMLSchema#string

Lillian Sung

http://www.w3.org/2001/XMLSchema#string

Mark Holdsworth

http://www.w3.org/2001/XMLSchema#string

Paula D Robinson

http://www.w3.org/2001/XMLSchema#string

Pediatric Oncology Group of Ontario

http://www.w3.org/2001/XMLSchema#string

Richard Hain

http://www.w3.org/2001/XMLSchema#string

Sabrina Boodhan

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Meta-analysis in clinical trials

Aggressive treatment of non-metastatic osteosarcoma improves health-related quality of life in children and adolescents.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis

Nabilone: an alternative antiemetic for cancer chemotherapy.

5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.

Acute and delayed nausea and emesis control in pediatric oncology patients.

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

P304

1073-1082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24508

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236064997

http://www.w3.org/2001/XMLSchema#string

P698

23512831

http://www.w3.org/2001/XMLSchema#string

P921